73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Number of cancer treatments provided decreased in first year of COVID-19

Number of cancer treatments provided decreased in first year of COVID-19

by Elana GotkineIn the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according

Number of cancer treatments provided decreased in first year of COVID-19

by Elana GotkineIn the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according
The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc
Cancer diagnoses dropped sharply in Alberta during COVID-19 response

Cancer diagnoses dropped sharply in Alberta during COVID-19 response

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainPandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well

Cancer diagnoses dropped sharply in Alberta during COVID-19 response

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainPandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well
Those with the BRCA1 gene mutation may face greater risk for aggressive cancer caused by asbestos exposure

Those with the BRCA1 gene mutation may face greater risk for aggressive cancer caused by asbestos exposure

byNagoya UniversityChrysotile-induced MMs present lower expression levels of Brca1. (A) Immunohistochemistry (IHC) staining of total BRCA1 on MM samples (bar=25 μm; N≧7).

Those with the BRCA1 gene mutation may face greater risk for aggressive cancer caused by asbestos exposure

byNagoya UniversityChrysotile-induced MMs present lower expression levels of Brca1. (A) Immunohistochemistry (IHC) staining of total BRCA1 on MM samples (bar=25 μm; N≧7).
Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projection images of 18F-fluorodeoxyglucose (FDG), 68Ga-FAP-2286, and 68Ga-FAPI-46 PET/CT imaging in seven patients with different

Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projection images of 18F-fluorodeoxyglucose (FDG), 68Ga-FAP-2286, and 68Ga-FAPI-46 PET/CT imaging in seven patients with different
Natural compound found in broccoli reawakens the function of potent tumor suppressor

Natural compound found in broccoli reawakens the function of potent tumor suppressor

by Beth Israel Deaconess Medical CenterCredit: CC0 Public DomainYour mother was right: Broccoli is good for you. Long associated with decreased risk of cancer, broccoli and other cruciferous vege

Natural compound found in broccoli reawakens the function of potent tumor suppressor

by Beth Israel Deaconess Medical CenterCredit: CC0 Public DomainYour mother was right: Broccoli is good for you. Long associated with decreased risk of cancer, broccoli and other cruciferous vege
An intelligent knife can tell ovarian cancer and healthy tissue apart. Could it make surgery smarter?

An intelligent knife can tell ovarian cancer and healthy tissue apart. Could it make surgery smarter?

by Katie Roberts,Cancer Research UKTesting the iKnife in the lab. Credit: Cancer Research UKSurgery is a major part of ovarian cancer treatment, but it can be a blunt tool.A big problem for surg

An intelligent knife can tell ovarian cancer and healthy tissue apart. Could it make surgery smarter?

by Katie Roberts,Cancer Research UKTesting the iKnife in the lab. Credit: Cancer Research UKSurgery is a major part of ovarian cancer treatment, but it can be a blunt tool.A big problem for surg
Immunotherapy comparable to chemo for some advanced stomach cancers

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food
Combination treatment improves survival in advanced prostate cancer with genetic mutations

Combination treatment improves survival in advanced prostate cancer with genetic mutations

by Melissa Rohman,Northwestern UniversityProstate cancer cells. Credit: NIH Image GalleryA combination therapy improved progression-free survival in patients with metastatic castration-resistant

Combination treatment improves survival in advanced prostate cancer with genetic mutations

by Melissa Rohman,Northwestern UniversityProstate cancer cells. Credit: NIH Image GalleryA combination therapy improved progression-free survival in patients with metastatic castration-resistant
Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel
What you need to know about flu vaccination if you have cancer

What you need to know about flu vaccination if you have cancer

by Laurel Kelly,Mayo ClinicCredit: Unsplash/CC0 Public DomainAs flu season approaches, it's important to understand the need to get vaccinated for influenza, or flu. Indications are it could

What you need to know about flu vaccination if you have cancer

by Laurel Kelly,Mayo ClinicCredit: Unsplash/CC0 Public DomainAs flu season approaches, it's important to understand the need to get vaccinated for influenza, or flu. Indications are it could
One lung cancer drug receives NHS England approval, while another is rejected

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d